|
Attapulgite
|
DB01574 |
[Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. Until 2003, it was the active ingredient used in Kaopectate, before that product was reformulated with bismuth subsalicylate.] |
|
Benzylmorphine
|
DB01573 |
|
|
Cladribine
|
DB00242 |
[An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.] |
|
Dobesilic acid
|
DB13529 |
|
|
Althea root
|
DB13525 |
|
|
Avadomide
|
DB14857 |
[Avadomide is under investigation in clinical trial NCT02031419 (Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma).] |
|
PF-05089771
|
DB14856 |
[PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).] |
|
Pentaerithrityl
|
DB13526 |
|
|
Fosifloxuridine nafalbenamide
|
DB14859 |
[Fosifloxuridine nafalbenamide is under investigation in clinical trial NCT03428958 (A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment).] |
|
Proglumetacin
|
DB13527 |
|
|
Chlormadinone
|
DB13528 |
|
|
Tadekinig alfa
|
DB14858 |
[Tadekinig alfa is under investigation in clinical trial NCT03113760 (Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency).] |
|
Alipogene tiparvovec
|
DB13521 |
|
|
Myrcludex B
|
DB14853 |
[Myrcludex B is under investigation in clinical trial NCT03546621 (A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D).] |
|
PRM-151
|
DB14852 |
[PRM-151 is under investigation in clinical trial NCT01981850 (A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis).] |
|
Mebicar
|
DB13522 |
|
|
2-(aminomethyl)phenol
|
DB14855 |
[2-(aminomethyl)phenol is under investigation in clinical trial NCT03556319 (2-HOBA: Multiple Dosing Study in Older Adults).] |
|
Veralipride
|
DB13523 |
|
|
Propyphenazone
|
DB13524 |
|
|
TC-6987
|
DB14854 |
[TC-6987 is under investigation in clinical trial NCT01296087 (TC-6987 for the Treatment of Mild to Moderate Asthma).] |
